XML 32 R14.htm IDEA: XBRL DOCUMENT v3.19.2
Share-Based Compensation
3 Months Ended
May 04, 2019
Share-based Payment Arrangement [Abstract]  
Share-Based Compensation SHARE-BASED COMPENSATION
For the thirteen weeks ended May 4, 2019 and May 5, 2018, share-based compensation expense was $1.5 million and $5.1 million, respectively. As of May 4, 2019, approximately 5.3 million shares remain available for future grants of equity awards under our Amended and Restated 2012 Omnibus Stock and Incentive Plan, which was amended and restated effective June 22, 2017.
Restricted Stock Awards
Restricted stock awards vest in equal annual installments over a three-year period from the date of grant.
Restricted stock award activity for the thirteen weeks ended May 4, 2019 was as follows:

Number of
Shares
 
Weighted
Average
Grant Date
Fair Value
Unvested, beginning of period
2,715,466

 
$
10.92

Granted
2,338,690

 
4.76

Vested
(1,043,156
)
 
11.72

Forfeited
(849,773
)
 
7.56

Unvested, end of period
3,161,227

 
7.00


Performance-based Restricted Stock Units
For the thirteen weeks ended May 4, 2019, we granted performance-based restricted stock units (“PSUs”), contingent upon the achievement of Company-specific performance goals during the three fiscal years 2019 - 2021. Any units earned as a result of the achievement of this goal will vest 100% three years from the date of grant and will be settled in shares of our common stock.
Performance-based restricted stock unit activity for the thirteen weeks ended May 4, 2019 was as follows:
 
Number of Units/
Shares
 
Weighted
Average
Grant Date
Fair Value
Unvested, beginning of period
1,067,338

 
$
11.40

Granted
1,170,650

 
4.23

Vested
(244,628
)
 
13.19

Forfeited
(927,109
)
 
7.60

Unvested, end of period
1,066,251

 
6.42


 
Stock Option Awards
For the thirteen weeks ended May 4, 2019 and May 5, 2018, we did not grant any stock options.
Stock option activity for the thirteen weeks ended May 4, 2019 was as follows:
 
Number of
Options
 
Weighted
 Average
Exercise Price
Outstanding, beginning of period
214,277

 
$
13.54

Granted

 

Exercised

 

Forfeited or expired

 

Outstanding and exercisable, end of period
214,277

 
13.54